A Japanese startup says it has conducted a clinical trial to transplant a sheet of cardiac muscle cells derived from human induced pluripotent stem (iPS) cells into a patient with a heart muscle disease. https://www.japantimes.co.jp/news/2025/07/29/japan/science-health/ips-trial-heart-treatment/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #ips #startups #heartdisease